Periprocedural Considerations for Anticoagulated Atrial Fibrillation Patients

被引：1

作者：

Collins-Yoder, Angela ^{[1
]}

Collins, Rachel E. ^{[2
]}

机构：

[1] Ascension Sacred Heart Pensacola, Capstone Coll Nursing, Box 870358, Tuscaloosa, AL 35487 USA

[2] Publix Pharm, Pensacola, FL USA

来源：

JOURNAL OF PERIANESTHESIA NURSING | 2019年 / 34卷 / 02期

关键词：

atrial fibrillation; direct acting oral anticoagulants (DOACs); perianesthesia risks; thrombosis risk; CHAD-VAS score; HAS BLED score; ORAL ANTICOAGULANTS; MANAGEMENT; RISK; ASSOCIATION; REVERSAL; IMPACT;

D O I：

10.1016/j.jopan.2018.05.014

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

Periprocedural patient instruction and coordination is an important piece in achieving safe outcomes for patients needing procedures and receiving anticoagulants for atrial fibrillation. Balancing the needs for anticoagulation versus bleeding during the procedure requires clinical reasoning and preparation. In this article, the current guidelines for use of anticoagulants with atrial fibrillation, the relevant pharmacology, and the use of standardized tools to quantify the risks of thrombus or bleeding in the procedures will be discussed. In addition, resources for examining the optimal practice for these case types will be provided. Perianesthesia health care providers are pivotal to lead relevant stakeholders in the perianesthesia setting work together to create protocols and individual plans of care for this patient population.

引用

页码：227 / 239

页数：13

共 27 条

[1] Management Overview: Taking a Patient with Intracranial Hemorrhage Related to Direct Oral Anticoagulants to the Operating Room [J].

Alturki, Abdulrahman ;

Alamri, Abdullah ;

Badawy, Mohamed ;

Teitelbaum, Jeanne .

WORLD NEUROSURGERY, 2016, 90 :262-267

[2]

[Anonymous], CHEST

[3]

[Anonymous], ATR FIBR FACT SHEET

[4]

[Anonymous], DAVIS DRUG GUIDE

[5]

[Anonymous], 2016, ADV ANESTH

[6] Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation [J].

Di Lullo, L. ;

Ronco, C. ;

Cozzolino, M. ;

Russo, D. ;

Russo, L. ;

Di Iorio, B. ;

De Pascalis, A. ;

Barbera, V. ;

Galliani, M. ;

Vitaliano, E. ;

Campana, C. ;

Santoboni, F. ;

Bellasi, A. .

THROMBOSIS RESEARCH, 2017, 155 :38-47

[7] Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation [J].

Eckman, Mark H. ;

Lip, Gregory Y. H. ;

Wise, Ruth E. ;

Speer, Barbara ;

Sullivan, Megan ;

Walker, Nita ;

Kissela, Brett ;

Flaherty, Matthew L. ;

Kleindorfer, Dawn ;

Baker, Peter ;

Ireton, Robert ;

Hoskins, Dave ;

Harnett, Brett M. ;

Aguilar, Carlos ;

Leonard, Anthony C. ;

Arduser, Lora ;

Steen, Dylan ;

Costea, Alexandru ;

Kues, John .

AMERICAN HEART JOURNAL, 2016, 176 :17-27

[8] Management of Periprocedural Anticoagulation A Survey of Contemporary Practice [J].

Flaker, Greg C. ;

Theriot, Paul ;

Binder, Lea G. ;

Dobesh, Paul P. ;

Cuker, Adam ;

Doherty, John U. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (02) :217-226

[9]

Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x

[10] Novel Oral Anticoagulants for Atrial Fibrillation [J].

Hankey, Graeme J. ;

Eikelboom, John W. .

CURRENT ATHEROSCLEROSIS REPORTS, 2013, 15 (08)

← 1 2 3 →